Kangstem Biotech Co., Ltd. (KOSDAQ:217730)

Kangstem Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	347,060	218,206	113,229	133,971	109,830	124,057
Market Cap Growth	187.98%	92.71%	-15.48%	21.98%	-11.47%	-36.85%
Enterprise Value	318,306	199,995	95,018	129,761	85,183	115,828
Last Close Price	3690.00	2320.00	1689.51	2003.15	2103.33	2375.78
PS Ratio	97.15	61.08	14.62	10.55	6.74	10.00
PB Ratio	5.03	3.16	2.62	2.67	2.08	1.74
P/TBV Ratio	6.65	4.18	2.68	2.82	2.27	1.85
EV/Sales Ratio	89.10	55.98	12.27	10.21	5.23	9.34
Debt / Equity Ratio	0.14	0.14	0.20	0.27	0.25	0.20
Net Debt / Equity Ratio	-0.42	-0.42	-0.23	-0.47	-0.44	-0.60
Net Debt / EBITDA Ratio	1.91	1.91	0.85	1.26	1.40	2.26
Net Debt / FCF Ratio	2.36	2.36	0.50	1.33	1.19	1.97
Asset Turnover	0.05	0.05	0.11	0.16	0.18	0.13
Inventory Turnover	3.26	3.26	4.76	21.16	18.57	17.37
Quick Ratio	4.75	4.75	2.92	2.07	2.73	3.38
Current Ratio	5.25	5.25	3.69	2.55	3.22	3.80
Return on Equity (ROE)	-18.65%	-18.65%	-15.18%	-45.17%	-32.55%	-36.40%
Return on Assets (ROA)	-16.06%	-16.06%	-13.52%	-17.59%	-13.99%	-15.31%
Return on Capital Employed (ROCE)	-24.10%	-24.10%	-30.80%	-36.40%	-31.00%	-26.40%
Earnings Yield	-3.02%	-4.80%	-6.77%	-16.38%	-18.43%	-17.21%
FCF Yield	-3.55%	-5.65%	-17.29%	-13.35%	-17.82%	-17.43%
Buyback Yield / Dilution	-53.92%	-23.10%	-38.90%	-7.02%	-36.23%	-24.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.